Experts name 3 top ASX shares to buy this week

These shares have been given the thumbs up by experts this week.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are looking for new additions to your portfolio, then it could be worth listening to what analysts are saying about the popular ASX shares named below, courtesy of The Bull

Here's what they are recommending this week:

Man using his device in an airport.

Image source: Getty Images

Dicker Data Ltd (ASX: DDR)

The team at Vestra Capital is positive on this software and hardware distributor and has named it as a buy this week.

Vestra highlights Dicker Data's strong top line growth, attractive dividend yield, and exposure to artificial intelligence (AI) spending as reasons to buy. It said:

This technology company distributes hardware and software solutions. It benefits from enterprise spending on AI capable servers, network upgrades and end point security hardware. It generated gross revenue of $2.1 billion in the first half of 2026, up 14.2 per cent on the prior corresponding period. Net profit after tax of $60.7 million was up 54.1 per cent. 

Management has upgraded full year gross revenue guidance to between $4.3 billion and $4.4 billion, alongside profit before tax guidance of between $162 million and $165 million. Double digit top line momentum, an appealing dividend yield and increasing exposure to AI infrastructure spending provides a bright outlook, in my view.

Pro Medicus Ltd (ASX: PME)

Over at Medallion Financial Group, it has named this medical imaging software provider as an ASX share to buy.

Medallion believes that recent share price weakness has created a buying opportunity for investors. It explains:

Pro Medicus is a global leader in medical imaging software, with its Visage platform increasingly adopted by major US hospital networks. Revenue of $261.7 million in full year 2026 rose 22.9 per cent on the prior corresponding period. Underlying net profit after tax of $144.7 million was up 24.1 per cent. Revenue and underlying net profit exceeded expectations, while the underlying earnings before interest and tax margin reached an exceptional 74.9 per cent. 

It signed 10 new contacts worth $407 million in full year 2026. It renewed six contracts on five year terms to the value of $141 million. Recent share price weakness provides an attractive entry point into a high quality growth businesses.

Seek Ltd (ASX: SEK)

Gray Perry Wealth Advisers is a fan of job listings giant Seek and is tipping it as an ASX share to buy this week.

The wealth adviser highlights Seek's improving return on equity and healthy dividend as reasons to be positive. It said:

Seek operates a leading online employment marketplace, with a dominant position in Australia and established operations across Asia. Its scalable model, strong margins and international expansion provide attractive long-term growth potential. Despite softer job-ad volumes, fiscal year 2026 net revenue rose 10 per cent and EBITDA increased 15 per cent, demonstrating pricing power and operational resilience. 

We're forecasting earnings to grow about 9.5 per cent annually in the next two years. An improving return on equity and a healthy dividend further support the investment case.

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Dicker Data. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man looking at his laptop and thinking.
Broker Notes

Buy, hold, sell: Pro Medicus, BHP, CBA shares

Let's start the week with some fresh ratings from the experts. 

Read more »

Two smiling colleagues looking at a tablet in a data centre.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Woman and man worker in quarry on excavation machine looking at a clipboard.
Broker Notes

Up 57%! Should I still buy Rio Tinto shares today?

A leading analyst provides his forecast for Rio Tinto’s rocketing shares.

Read more »

A guy shrugs his shoulders, not sure which is the right decision.
Broker Notes

Buy, hold, sell: South32, Australian Finance Group and Magellan shares

One downgrade, one warning, one buy.

Read more »

A man in a business suit slides down the handrails of a bank of steel escalators, clutching his documents and telephone.
Broker Notes

9 ASX shares downgraded by experts post-results this week

Brokers have downgraded WiseTech, Ampol, Perseus Mining, Harvey Norman, and others.

Read more »

Woman using her laptop with her feet up.
Broker Notes

Buy, hold, sell: Wesfarmers, Endeavour, Macquarie shares

Analysts rate this ASX 200 retail and industrial conglomerate, liquor retailer, and investment bank.

Read more »

A boy dressed in a business suit and old-fashioned flying helmet and goggles is lifted by a bunch of red helium balloons over a barren desert landscape.
Broker Notes

8 ASX shares upgraded by the professionals post-results this week

Brokers raised their ratings on Telstra, Paladin Energy, Magellan, and other shares this week. 

Read more »

Stacked gold bricks.
Broker Notes

Up 83%! 4 reasons I'd still buy this $8 billion ASX 200 gold stock today

A leading expert forecasts more outperformance from this surging ASX gold stock.

Read more »